Russell Kevin Klass - Jun 10, 2024 Form 4 Insider Report for Zomedica Corp. (ZOM)

Role: Vice President of Sales
Signature: /s/ Russell Kevin Klass
Stock symbol: ZOM
Transactions as of: Jun 10, 2024
Transactions value $: $105,041
Form type: 4
Date filed: 6/12/2024, 04:15 PM
Previous filing: Nov 9, 2023
Next filing: Jun 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZOM	Common Stock, without par value	Purchase	$29.9K	+200K	+20%	$0.15	1.2M	Jun 10, 2024	Direct	F1
transaction	ZOM	Common Stock, without par value	Purchase	$75.1K	+500K	+41.66%	$0.15	1.7M	Jun 11, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.
F2	The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Content

The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.